227 related articles for article (PubMed ID: 32602961)
21. Weak cytotoxic activity of miltefosine against clinical isolates of Acanthamoeba spp.
Mrva M; Garajová M; Lukáč M; Ondriska F
J Parasitol; 2011 Jun; 97(3):538-40. PubMed ID: 21506779
[TBL] [Abstract][Full Text] [Related]
22. Acanthamoeba castellanii encephalitis in a patient with AIDS: a case report and literature review.
Damhorst GL; Watts A; Hernandez-Romieu A; Mel N; Palmore M; Ali IKM; Neill SG; Kalapila A; Cope JR
Lancet Infect Dis; 2022 Feb; 22(2):e59-e65. PubMed ID: 34461057
[TBL] [Abstract][Full Text] [Related]
23. Bioassay guided isolation and identification of anti-Acanthamoeba compounds from Tunisian olive leaf extracts.
Sifaoui I; López-Arencibia A; Ticona JC; Martín-Navarro CM; Reyes-Batlle M; Mejri M; Lorenzo-Morales J; Jiménez AI; Valladares B; Lopez-Bazzocchi I; Abderabba M; Piñero JE
Exp Parasitol; 2014 Nov; 145 Suppl():S111-4. PubMed ID: 24726697
[TBL] [Abstract][Full Text] [Related]
24. Contact lens care solution killing efficacy against Acanthamoeba castellanii by in vitro testing and live-imaging.
Kolar SS; Manarang JC; Burns AR; Miller WL; McDermott AM; Bergmanson JP
Cont Lens Anterior Eye; 2015 Dec; 38(6):442-50. PubMed ID: 26208952
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial Photodynamic Therapy with the photosensitizer TONS504 eradicates Acanthamoeba.
Pertiwi YD; Chikama T; Sueoka K; Ko JA; Kiuchi Y; Onodera M; Sakaguchi T
Photodiagnosis Photodyn Ther; 2019 Dec; 28():166-171. PubMed ID: 31499180
[TBL] [Abstract][Full Text] [Related]
26. Comparative proteomic analysis of soluble and surface-enriched proteins from Acanthamoeba castellanii trophozoites.
Maschio VJ; Virginio VG; Ferreira HB; Rott MB
Mol Biochem Parasitol; 2018 Oct; 225():47-53. PubMed ID: 30205118
[TBL] [Abstract][Full Text] [Related]
27. Bioinformatic Insights on Target Receptors of Amiodarone in Human and Acanthamoeba castellanii.
Baig AM; Rana Z; Tariq SS; Ahmad HR
Infect Disord Drug Targets; 2017; 17(3):160-177. PubMed ID: 28637420
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba.
Martín-Navarro CM; López-Arencibia A; Arnalich-Montiel F; Valladares B; Piñero JE; Lorenzo-Morales J
Graefes Arch Clin Exp Ophthalmol; 2013 Sep; 251(9):2111-7. PubMed ID: 23686225
[TBL] [Abstract][Full Text] [Related]
29. Alkyl-carbon chain length of two distinct compounds and derivatives are key determinants of their anti-Acanthamoeba activities.
Mooney R; Masala M; Martial T; McGinness C; Henriquez FL; Williams RAM
Sci Rep; 2020 Apr; 10(1):6420. PubMed ID: 32286337
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of contact lens storage solutions against trophozoite and cyst of Acanthamoeba castellanii strain 1BU and their cytotoxic potential on corneal cells.
Polat ZA; Vural A; Cetin A
Parasitol Res; 2007 Sep; 101(4):997-1001. PubMed ID: 17514482
[TBL] [Abstract][Full Text] [Related]
31. Acanthamoeba castellanii phosphate transporter (AcPHS) is important to maintain inorganic phosphate influx and is related to trophozoite metabolic processes.
Carvalho-Kelly LF; Pralon CF; Rocco-Machado N; Nascimento MT; Carvalho-de-Araújo AD; Meyer-Fernandes JR
J Bioenerg Biomembr; 2020 Apr; 52(2):93-102. PubMed ID: 31965457
[TBL] [Abstract][Full Text] [Related]
32. Malabaricones from the fruit of Myristica cinnamomea King as potential agents against Acanthamoeba castellanii.
Ahmed U; Sivasothy Y; Khan KM; Khan NA; Wahab SMA; Awang K; Othman MA; Anwar A
Acta Trop; 2023 Dec; 248():107033. PubMed ID: 37783284
[TBL] [Abstract][Full Text] [Related]
33. Amoebicidal activity of cationic carbosilane dendrons derived with 4-phenylbutyric acid against Acanthamoeba griffini and Acanthamoeba polyphaga trophozoites and cysts.
López-Barona P; Verdú-Expósito C; Martín-Pérez T; Gómez-Casanova N; Lozano-Cruz T; Ortega P; Gómez R; Pérez-Serrano J; Heredero-Bermejo I
Sci Rep; 2022 Sep; 12(1):14926. PubMed ID: 36056060
[TBL] [Abstract][Full Text] [Related]
34. The Anti-Amoebic Activity of a Peptidomimetic against
Peguda HK; Carnt NA; Gu Z; Kumar N; Willcox MDP; Kuppusamy R
Microorganisms; 2022 Nov; 10(12):. PubMed ID: 36557630
[TBL] [Abstract][Full Text] [Related]
35. Lactase can target cellular differentiation of Acanthamoeba castellanii belonging to the T4 genotype.
Simau FA; Ahmed U; Khan KM; Khan NA; Siddiqui R; Alharbi AM; Alfahemi H; Anwar A
Parasitol Res; 2024 Jan; 123(2):117. PubMed ID: 38294565
[TBL] [Abstract][Full Text] [Related]
36. Functional importance for developmental regulation of sterol biosynthesis in Acanthamoeba castellanii.
Zhou W; Warrilow AGS; Thomas CD; Ramos E; Parker JE; Price CL; Vanderloop BH; Fisher PM; Loftis MD; Kelly DE; Kelly SL; Nes WD
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1164-1178. PubMed ID: 30044954
[TBL] [Abstract][Full Text] [Related]
37. In vitro evaluation of the amoebicidal activity of garlic (Allium sativum) extract on Acanthamoeba castellanii and its cytotoxic potential on corneal cells.
Polat ZA; Vural A; Ozan F; Tepe B; Ozcelik S; Cetin A
J Ocul Pharmacol Ther; 2008 Feb; 24(1):8-14. PubMed ID: 18370873
[TBL] [Abstract][Full Text] [Related]
38. In vitro efficacy of corifungin against Acanthamoeba castellanii trophozoites and cysts.
Debnath A; Tunac JB; Silva-Olivares A; Galindo-Gómez S; Shibayama M; McKerrow JH
Antimicrob Agents Chemother; 2014; 58(3):1523-8. PubMed ID: 24366747
[TBL] [Abstract][Full Text] [Related]
39. Amoebicidal efficacy of a novel multi-purpose disinfecting solution: first findings.
Ustüntürk M; Zeybek Z
Exp Parasitol; 2014 Nov; 145 Suppl():S93-7. PubMed ID: 24858922
[TBL] [Abstract][Full Text] [Related]
40. Tigecycline inhibits proliferation of Acanthamoeba castellanii.
Jha BK; Seo I; Kong HH; Suh SI; Suh MH; Baek WK
Parasitol Res; 2015 Mar; 114(3):1189-95. PubMed ID: 25563616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]